Adaptive Biotechnologies Corporation
ADPT$1.39B
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaSEATTLE619 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 4, 2026
7wMarket Overview
Stock performance and key metrics
ADPT News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
No drugs found in this phase.
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply